William Blair & Company
UTHR icon

William Blair & Company’s United Therapeutics UTHR Stock Holding History

William Blair & Company’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$949K Sell
1,600
-200
-11% -$99.6K ﹤0.01% 962
2025
Q4 		$877K Buy
1,800
+510
+40% +$238K ﹤0.01% 971
2025
Q3 		$541K Sell
1,290
-53
-4% -$17.8K ﹤0.01% 1086
2025
Q2 		$386K Buy
1,343
+243
+22% +$72.6K ﹤0.01% 1169
2025
Q1 		$339K Sell
1,100
-32
-3% -$11K ﹤0.01% 1210
2024
Q4 		$399K Buy
1,132
+6
+0.5% +$2.21K ﹤0.01% 1170
2024
Q3 		$404K Sell
1,126
-1
-0.1% -$338 ﹤0.01% 1187
2024
Q2 		$359K Sell
1,127
-435
-28% -$115K ﹤0.01% 1203
2024
Q1 		$359K Buy
1,562
+29
+2% +$6.54K ﹤0.01% 1192
2023
Q4 		$337K Buy
1,533
+17
+1% +$3.92K ﹤0.01% 1204
2023
Q3 		$342K Buy
1,516
+16
+1% +$3.69K ﹤0.01% 1176
2023
Q2 		$331K Buy
+1,500
New +$332K ﹤0.01% 1211
2022
Q1 		– Sell
-3,053
Closed -$660K – 2014
2021
Q4 		$660K Buy
+3,053
New +$599K ﹤0.01% 1108
2014
Q4 		– Sell
-1,600
Closed -$206K – 2150
2014
Q3 		$206K Buy
+1,600
New +$165K ﹤0.01% 1964

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

William Blair & Company's UTHR Position: Q1 2026 in Review

William Blair & Company reduced its United Therapeutics (UTHR) stake by 11% in Q1 2026, selling an estimated $99.6K and leaving 1,600 shares worth $949K. The position accounts for ﹤0.01% of the portfolio, ranked #962.

William Blair & Company first reported a position in UTHR in Q3 2014 and has held it in 14 quarters since. 852 funds tracked by Wall St. Rank hold UTHR as of Q1 2026.

  • William Blair & Company held 1,600 shares of United Therapeutics worth $949K as of Q1 2026.
  • William Blair & Company sold 200 United Therapeutics shares in Q1 2026, an estimated $99.6K.
  • United Therapeutics made up ﹤0.01% of William Blair & Company's portfolio in Q1 2026, its #962 holding.
  • William Blair & Company first reported a position in United Therapeutics in Q3 2014 and has held it in 14 quarters since.
  • 852 funds tracked by Wall St. Rank held United Therapeutics as of Q1 2026.

Based on William Blair & Company's 13F filing for Q1 2026, filed 8 May 2026.